Drug Topics

MARCH 23, 2025

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed the various errors patients experience when using CGM devices.

368

368

Pharmacy Times

MARCH 23, 2025

In a debate at the 2025 APhA Annual Meeting, speakers highlighted GLP-1s advantages in stroke prevention and weight loss vs SGLT2s superiority in heart failure, CV death reduction, and renal protection.

137

137

Drug Topics

MARCH 23, 2025

Jeffrey Gudin, MD, faculty in the department of anesthesiology and pain management at the University of Miami, said topical analgesics are safer alternatives to systemic medications.

363

363

The FDA Law Blog

MARCH 23, 2025

By Deborah L. Livornese On Friday, March 21, 2025, FDA announced that it was further delaying the effective date for the ACNU final rule until May 27, 2025. We wrote about the December 26, 2024 publication of the final rule (89 FR 105288) here. Originally, the Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) final rule was to become effective January 27, 2025.

FDA 59

FDA Labelling 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MARCH 23, 2025

Stefanie Ferreri, PharmD, BCACP, FAPhA, discusses literature exploring OTC drugs, supplements, and devices used for non-prescription or self-care purposes.

315

315

Pharmacy Times

MARCH 23, 2025

Jeff A. Goad, PharmD, MPH, discusses the latest RSV vaccination guidelines and recommendations for 2025, highlighting vaccine options, target populations, timing considerations, evolving CDC policies, and the role of pharmacists in immunization efforts.

Vaccines 73

Vaccines Immunization 73

Pharmacy Times

MARCH 23, 2025

Pharmacists are pivotal in expanding reproductive health care access through patient education and collaboration.

73

73

Drug Topics

MARCH 23, 2025

Darcy Aslett, PharmD, residency program director for PGY-1 community-based residency at St. Luke's Health System, discusses clinical services in pharmacies for underserved patients.

190

190

Pharmacy Times

MARCH 23, 2025

Automation can enhance medication management and support pharmacists' critical clinical roles.

65

65

Med Ed 101

MARCH 23, 2025

Modafinil (Provigil) is a stimulant type of medication that is most often utilized in narcolepsy. In my geriatric practice, I do see occasional off-label use to help stimulate energy in patients who are experiencing fatigue. I’ll outline my top 5 modafinil clinical pearls. Modafinil Clinical Pearls Polypharmacy is a problem in my geriatric patient population. […] The post Top 5 Modafinil Clinical Pearls appeared first on Med Ed 101.

Labelling 52

Labelling 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

MARCH 23, 2025

Pharmacists are leading the way in personalized medicine through strategic pharmacogenetic implementation.

65

65

The Guardian - Pharmaceutical Industry

MARCH 23, 2025

Corporate backsliding on climate and diversity policies mean this years annual meetings may be tough for some of the UKs biggest companies The leafy surroundings of Sunbury-on-Thames in Surrey will provide an unlikely backdrop for potentially one of the most explosive events of an intriguing shareholder meeting season, as corporate Britain grapples with a rapidly shifting geopolitical backdrop.

49

49